BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 1320526)

  • 1. Clinical effects and mechanism of action of sumatriptan in migraine.
    Ferrari MD; Saxena PR
    Clin Neurol Neurosurg; 1992; 94 Suppl():S73-7. PubMed ID: 1320526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin receptors and headache.
    Raskin NH
    N Engl J Med; 1991 Aug; 325(5):353-4. PubMed ID: 1647497
    [No Abstract]   [Full Text] [Related]  

  • 3. [Sumatriptan in migraine and cluster headache].
    Ferrari MD
    Ned Tijdschr Geneeskd; 1991 Aug; 135(35):1573-5. PubMed ID: 1656279
    [No Abstract]   [Full Text] [Related]  

  • 4. Rationale for the use of 5-HT1-like agonists in the treatment of migraine.
    Feniuk W; Humphrey PP; Perren MJ; Connor HE; Whalley ET
    J Neurol; 1991; 238 Suppl 1():S57-61. PubMed ID: 1646289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sumatriptan in acute migraine: pharmacology and review of world experience.
    Peroutka SJ
    Headache; 1990; 30 Suppl 2():554-60. PubMed ID: 2177047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SUMATRIPTAN: a receptor-targeted treatment for migraine.
    Moskowitz MA; Cutrer FM
    Annu Rev Med; 1993; 44():145-54. PubMed ID: 8386498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sumatriptan in clinical practice].
    Ferrari MD; Haan J; Visser WH; Saxena PR; Bax WA; Mulder LJ
    Ned Tijdschr Geneeskd; 1993 Apr; 137(17):850-5. PubMed ID: 8387649
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of migraine attacks with sumatriptan.
    Subcutaneous Sumatriptan International Study Group
    N Engl J Med; 1991 Aug; 325(5):316-21. PubMed ID: 1647495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache.
    Dechant KL; Clissold SP
    Drugs; 1992 May; 43(5):776-98. PubMed ID: 1379152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sumatriptan and its use in treatment of migraine and cluster headaches].
    PrusiƄski A
    Neurol Neurochir Pol; 1992; Suppl 2():28-48. PubMed ID: 1337766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sumatriptan: efficacy and contribution to migraine mechanisms.
    Pearce JM
    J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1103-5. PubMed ID: 1336041
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of acute cluster headache with sumatriptan.
    Sumatriptan Cluster Headache Study Group
    N Engl J Med; 1991 Aug; 325(5):322-6. PubMed ID: 1647496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From serotonin receptor classification to the antimigraine drug sumatriptan.
    Saxena PR; Ferrari MD
    Cephalalgia; 1992 Aug; 12(4):187-96. PubMed ID: 1326401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible benefit of GR43175, a novel 5-HT1-like receptor agonist, for the acute treatment of severe migraine.
    Doenicke A; Brand J; Perrin VL
    Lancet; 1988 Jun; 1(8598):1309-11. PubMed ID: 2897560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin receptor subtypes and neuropsychiatric diseases: focus on 5-HT1D and 5-HT3 receptor agents.
    Peroutka SJ
    Pharmacol Rev; 1991 Dec; 43(4):579-86. PubMed ID: 1663621
    [No Abstract]   [Full Text] [Related]  

  • 16. Sumatriptan is a potent vasoconstrictor of human dural arteries via a 5-HT1-like receptor.
    Jansen I; Edvinsson L; Mortensen A; Olesen J
    Cephalalgia; 1992 Aug; 12(4):202-5. PubMed ID: 1326402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sumatriptan for migraine.
    Med Lett Drugs Ther; 1992 Oct; 34(880):91-3. PubMed ID: 1326077
    [No Abstract]   [Full Text] [Related]  

  • 18. Methodology of clinical trials of sumatriptan in migraine and cluster headache.
    Pilgrim AJ
    Eur Neurol; 1991; 31(5):295-9. PubMed ID: 1653136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of mRNA for the serotonin 5-hydroxytryptamine1D beta receptor subtype in human and bovine cerebral arteries.
    Hamel E; Fan E; Linville D; Ting V; Villemure JG; Chia LS
    Mol Pharmacol; 1993 Aug; 44(2):242-6. PubMed ID: 8394988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The selectivity of MDL 74,721 in models of neurogenic versus vascular components of migraine.
    Petty MA; Elands J; Johnson MP; Linnik MD; Hamel E; Moskowitz MA; Lee WS; McCarty DR; Hibert M; Baron BM
    Eur J Pharmacol; 1997 Oct; 336(2-3):127-36. PubMed ID: 9384224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.